Leadership for success in transforming medical abortion policy in Canada. by Dineley, Brigid et al.
LSHTM Research Online
Dineley, Brigid; Munro, Sarah; Norman, Wendy V; (2020) Leadership for success in transform-
ing medical abortion policy in Canada. PloS one, 15 (1). e0227216-. ISSN 1932-6203 DOI:
https://doi.org/10.1371/journal.pone.0227216
Downloaded from: http://researchonline.lshtm.ac.uk/id/eprint/4656085/
DOI: https://doi.org/10.1371/journal.pone.0227216
Usage Guidelines:
Please refer to usage guidelines at https://researchonline.lshtm.ac.uk/policies.html or alternatively
contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
https://researchonline.lshtm.ac.uk
RESEARCH ARTICLE
Leadership for success in transforming
medical abortion policy in Canada
Brigid DineleyID1*, Sarah Munro1,2, Wendy V. NormanID3,4
1 Department of Obstetrics & Gynecology, University of British Columbia, Vancouver, Canada, 2 Centre for
Health Evaluation and Outcome Sciences (CHE´ OS), Vancouver, Canada, 3 Department of Family Practice,
University of British Columbia, Vancouver, Canada, 4 Faculty of Public Health & Policy, London School of
Hygiene & Tropical Medicine, London, England
* brigid.dineley@cw.bc.ca
Abstract
Objectives
Mifepristone was approved for use in medical abortion by Health Canada in 2015. Approval
was accompanied by regulations that prohibited pharmacist dispensing of the medication.
Reproductive health advocates in Canada recognized this regulation would limit access to
medical abortion and successfully worked to have this regulation removed in 2017. The pur-
pose of this study was to assess the leadership involved in changing these regulations so
that the success may be replicated by other groups advocating for health policy change.
Methods
This study involved a mixed methods instrumental design in the context of British Columbia,
Canada. Our data collection included: a) interviews with seven key individuals, representing
the organizations that worked in concert for change to Canadian mifepristone regulations,
and b) document analysis of press articles, correspondence, briefing notes, and meeting
minutes. We conducted a thematic analysis of transcripts of audio-recorded interviews. We
identified strengths and weaknesses of the team dynamic using the Develop Coalitions,
Achieve Results and Systems Transformation domains of the LEADS Framework.
Results
Our analysis of participant interviews indicates that autonomy, shared values, and clarity in
communication were integral to the success of the group’s work. Analysis using the LEADS
Framework showed that individuals possessed many of the capabilities identified as being
necessary for successful health policy leadership. A lack of post-project assessment was
identified as a possible limitation and could be incorporated in future work to strengthen
dynamics especially when a desired outcome is not achieved. Document analysis provided
a clear time-line of the work completed and suggested that strong communication between
team members was another key to success.
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Conclusions
The results of our analysis of the interviews and documents provide valuable insight into the
workings of a successful group committed to a common goal. The existing collegial and
trusting relationships between key stakeholders allowed for interdisciplinary collaboration,
rapid mobilization, and identification of issues that facilitated successful Canadian global-
first deregulation of mifepristone dispensing.
Introduction
In Canada, abortion was decriminalized in 1988, and it remains the only country in the world
to have fully enacted decriminalization. [1,2] There are currently no Canadian criminal laws
restricting abortion access. For example, this includes that Canada has no criminal law stipu-
lating restrictions on gestational age and there are no criminal laws which require authoriza-
tion from a medical board, or a specified number or type of physician, prior to obtaining a
procedure. [2] In Canada, abortion care is regulated as any other medical service; governed by
provincial health professional regulators and health system authorities. Following decriminal-
ization there was an attempt to restrict access through provincial channels, but currently the
only regulations that exist are designed to improve access to abortion services. [2] Despite this,
The UN Human Rights Commissioner’s report identified that access to abortion in Canada is
known to be unequally distributed. [3] This inequity is caused by the monetary cost of some
abortion services, the challenges with awareness of how to access services and the geography of
providers. [2] The majority of providers are located in urban centres and there is minimal pro-
vision in rural and remote locations. [4] Due to this clustering of providers, individuals seeking
abortion care who do not reside in these urban centres must travel to access care, resulting in
increased time away from work, family obligations, social supports, as well as substantial mon-
etary costs for travel and accommodation. [4–6]
Medical abortion offers a potential solution to the geography of providers, with the ability
to provide abortions without the need for a surgical centre or surgical training. [7] Medical
abortion involves two medications: mifepristone and misoprostol, which are taken 24–48
hours apart. It is a safe and effective way to terminate a pregnancy up to 70 days gestational
age. [8] The medications are dispensed together in one box, in separate colour coded packages,
and are distributed in Canada under the brand name Mifegymiso1 by Celopharma. [8] This
medication could address geography-related access problems by being distributed through pri-
mary care networks as well as through telemedicine services.
Mifepristone was first approved for use in Canada in 2015. When Health Canada approved
the medication several restrictions to dispensing were put in place. [7,8] Most notably, physi-
cians were required to dispense the medication directly to patients and pharmacists were
restricted from this role. [9] Other restrictions included observed ingestion and mandatory
completion of education modules for all providers. [7] These restrictions were similar to those
introduced in other countries such as the US, where supervised ingestion was mandated. [10]
Australia also continues to experience a variety of regulatory barriers depending on geographic
location and research has indicated that these regulations limit provision of medical abortion
by primary care professionals. [11] When the Canadian restrictions were announced, advo-
cates for abortion access raised concerns that they would limit particularly the potential for
primary care provision and thus access to abortion. Further, there was no evidence that the
restrictions would improve patient safety. [7] Provincial frameworks also discouraged or
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restricted physician dispensing. In BC, for instance, physician dispensing would require access
to Pharmanet (a central data system tracking every prescription in the province) and special
permission from the College of Physicians and Surgeons of British Columbia (CPSBC). [12,13]
Physician-only dispensing of mifepristone was perceived by advocates to be an unnecessary
barrier that, if removed, would dramatically impact patient access to abortion by encouraging
uptake of the provision of medical abortion care among prescribers and pharmacists.
The purpose of this study was to investigate the leadership skills that were used to advocate
for changing, and successfully removing, the restrictions on pharmacist dispensing of mifep-
ristone in BC over the course of twelve months in 2016–2017. This work was done by physi-
cians, pharmacists, public health experts and hospital executives who worked in parallel,
engaging with each other as needed while each working within their own organizations and
areas of expertise to improve access to necessary health care for individuals in BC. This work
will be termed “the project” for the remainder of this paper. Our investigation of these leader-
ship skills is important to provide insight into the functioning of a successful team and a
potential guide to skill development for other teams working on policy.
Methods
This study employed a single site, mixed methods instrumental design to assess the leadership
involved in the project using the Lead self, Engage others, Achieve results, Develop Coalitions
and Systems Transformation (LEADS) framework.
Analysis framework
The LEADS framework provides a summary of the key skills, attitudes, and qualities necessary
to foster change while working within the Canadian health system. [14] The LEADS Collabo-
rative is a partnership between the Canadian College of Health Leaders the Canadian Health
Leadership Network, Royal Roads University and Dr. Graham Dickson. [14] The framework
was developed in BC in conjunction with several large health sector employers and the Health
Care Leaders Association of BC. The framework was initially designed specifically for BC and
was then scaled up to incorporate a Canadian wide approach. [15] The LEADS framework
consists of 5 domains: Lead Self, Engage Others, Achieve Results, Develop Coalitions, and Sys-
tems Transformation. [14] The framework assesses leadership from an individual to systems
level.
We chose the LEADS framework to analyze our data as it directly applies to the Canadian
setting in which the project was undertaken. We felt that it would provide a relevant evaluation
of leadership qualities given that it was designed by Canadian health care institutions for use
in the Canadian health care system, to document the leadership attributes necessary to drive
change within the Canadian health care system. The framework stresses that leadership and
management skills must combine together in order to stimulate and sustain change. Use of the
framework has been shown to foster stakeholder engagement in systems change by employing
a common language and set of standards. [15] Leadership is necessary to foster an environ-
ment where positive, evidence-based change can be introduced by all levels of a team.[16] Our
focus was on leadership skills used by the individuals in the team that facilitated a successful
policy change and therefore, because we were not explicitly exploring the policy change itself,
we did not feel it would be appropriate to use a policy framework for analysis.
We felt that the Leads Self domain was not as applicable to the study as it emphasizes skills
of self-awareness and emotional intelligence that we felt would be difficult to assess through an
interview process. We also identified that the Engage Others domain was more applicable to
formal team structures, which was not the way the individuals involved in the project were
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organized. Through research team discussion and deliberation, we determined the most rele-
vant domains to be: Achieve Results, Develop Coalitions, and Systems Transformation.
Recruitment
BD identified WN as a key stakeholder and proposed the study. WN’s role as the Director of
the Contraception & Abortion Research Team, CART-GRAC, provided a unique opportunity
to assist with recruitment, design and analysis. CART-GRAC is a Canadian multi-disciplinary
team that carries out research on topics identified by policy leaders, community groups, and
health care providers with the objective of improving access to family planning care for all
Canadians. Their work on mifepristone implementation in Canada is supported by a grant
from CIHR (PHE148161), in partnership with the Michael Smith Foundation for Health
Research (Award #16743).
BD interviewed key stakeholders involved in the project in BC, identified through snowball
sampling. We (BD, WN) initially developed a list of potential participants and expanded it as
input from these key stakeholders was incorporated. We contacted potential participants via
email and asked if they would be interested in completing an interview to discuss their role in
the project. In the email we gave a brief description of the goal of the study and explained that
we would be employing the LEADS Framework to perform our analysis. We obtained written
consent at the time of the interviews. Inclusion criteria included any individuals identified by
another member of the group to have had a significant role in the project. We reviewed the list
with each participant at the time of their interview to solicit feedback and to determine if any
individuals had been missed. Our participant list was determined to be complete when no fur-
ther names were generated by the current participants. Study participants were assigned a ran-
dom, unique three digit study identifier.
Interviews
Written consent was obtained prior to all interviews which were recorded by the author and
transcribed. We completed interviews in person, by email, and over the phone. The lead
author (BD) carried out all interviews. The interview questions were based on a previously
employed interview guide used by the CART team to assess stakeholder engagement in mifep-
ristone implementation work and modified to directly assess the domains of the LEADS
framework. [17]Interview questions were developed with a priori knowledge of the team
members and their multi-disciplinary nature. We employed a semi-structured interview guide
for all participants, ensuring that we addressed all domains with all participants. The interview
guide also included a description of the LEADS framework. Example questions included:
1. Describe your role in the work that was done to remove the requirement that physicians
dispense mifepristone:
a. When and how did you get involved?
b. Who was on the team, was there a clearly defined leader?
c. What was your experience working with this team?
d. Did you have any role in engaging hospital executive members
e. How was progress on the project measured?
2. Describe the process of working with multiple stakeholders to achieve results
a. How were these stakeholders identified?
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b. How important was inter-disciplinary collaboration to the success of this project?
c. Was communication uni or bi-directional?
d. Was the exchange of ideas between groups easy or difficult?
Analysis
BD analyzed the interviews using the LEADS framework, specifically looking at the domains
of Achieve Results, Develop Coalitions, and Systems Transformation. Each interview was
assessed through the lens of each domain. We documented the presence and absence of the
key capabilities of each domain in each interview. Using this method, we were able to identify
which capabilities were present and which were absent. Strengths and weaknesses of the team
dynamic were identified. Extensive field notes were taken during and after each interview to
assist in analysis.
In addition to interviews with key stakeholders, textual analysis of a variety of documents
was conducted to create a cohesive timeline of events and to assess elements of teamwork.
These documents included: press articles, submissions to Health Canada, emails between team
members, briefing notes for the College of Physicians and Surgeons of BC board meetings,
and Proceedings from the annual CART research meeting at BC Women’s Hospital. [9,18–25]
Ethics approval was obtained through the University of British Columbia Children’s and
Women’s Hospital ethics review board (H16-01006). All documents reviewed were released to
the author in accordance with the Freedom of Information act.
As WN was both a participant in this study and a member of the research team. Bias was
mitigated in study design by development of the interview questions (SM, BD) independent of
input from WN. As well, factual information provided in her interview (such as the timeline of
the project) was verified via document analysis of information that was obtained from other
participants as well as through the interviews with other team members. In order to ensure
that there was no bias in the identification of stakeholders, the other participants were asked to
suggest additional potential individuals who played a meaningful role in the project. Finally,
analysis of the data was carried out by BD and SM without input by WN.
Results
Identification of stakeholders
In total we completed seven interviews. See Fig 1 for an illustration of the recruitment process.
Document analysis
Fig 2 outlines the timeline of policy change.
Leadership analysis
The LEADS domains were used to analyse the transcripts. Fig 3 explains the domains and
their respective capabilities.
Develop coalitions. According to the LEADS Framework, collaboration is a central part
of making changes to health policy.[14] Develop Coalitions is a key domain in successful lead-
ership and involves an understanding of the Theory of Collaborative Advantage, which stresses
that collaborations must be actively built and sustained in order to be successful. [26] The four
capabilities of the Develop Coalitions domain are: a) purposefully building partnerships and
networks to create results, b) mobilizing knowledge, c) demonstrating a commitment to cus-
tomers and service, and c) successfully navigating socio-political environments. [26]
Leadership for success in transforming medical abortion policy in Canada
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Fig 1. Recruitment timeline.
https://doi.org/10.1371/journal.pone.0227216.g001
Fig 2. Timeline of policy change.
https://doi.org/10.1371/journal.pone.0227216.g002
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There were multiple interlocking coalitions created during the course of the project. Our
analysis of the interviews revealed collaboration between the CART team, the College of Physi-
cians and Surgeons of BC, the College of Pharmacists of BC, the executive at BC Women’s
Hospital, and members of provincial and federal governments. These overlapping coalitions
will be evaluated on the basis of each of the four elements of the Develop Coalitions domains.
Develop coalitions: Purposefully building partnerships. Our analysis of interviews sug-
gest that the type of collaboration pursued during the project fit into the category of joint ven-
tures; where the members of the groups were working together towards the common goal of
removing the restrictions on the dispensing of mifepristone. These collaborations were highly
strategic. The CART team identified the key stakeholders that would help to move the project
forward. They were then able to provide the best medical evidence to support the regulatory
bodies in communicating with Health Canada to produce change.
“Our research team was able to support them (regulatory bodies) taking a stand against the
federal regulator founded by the best evidence as well as on their regulatory structure.”
(P742)
Importantly, multiple individuals we interviewed communicated that these partnerships
had been formed in previous projects and so trust and mutual respect were present, which
made collaboration and partnership building faster and simpler.
Fig 3. LEADS domains and respective capabilities analyzed12-14.
https://doi.org/10.1371/journal.pone.0227216.g003
Leadership for success in transforming medical abortion policy in Canada
PLOS ONE | https://doi.org/10.1371/journal.pone.0227216 January 8, 2020 7 / 16
“For me it was like dropping the stone in the puddle because we have these established con-
nections already . . . it was pretty easy to get a message out.” (P328)
“There is trust and credibility . . . comfort that someone isn’t trying to get something done
that doesn’t align with our values.” (P390)
Partnerships used in the project were selected with clear intent; every member had
resources in the form of knowledge, expertise, advocacy, government contacts, and/or regula-
tory authority.
Develop coalitions: Mobilizing knowledge. Our analysis of the interviews also demon-
strated themes of knowledge transfer and evidence sharing. Specifically, the CART team was
cited as being able to provide medical evidence to the board of the College of Physicians and
Surgeons of BC as well as to the board of the College of Pharmacists of BC on mifepristone,
medical abortion, and the lack of access to abortion care for many Canadians. Additionally,
knowledge of the policy of medication prescribing practices was communicated by the College
of Pharmacists of BC to the other coalition members. These key education points were com-
bined to achieve both “Know-how,” or how the policy should be changed, and “Know-why,”
or what evidence supported the removal of the barriers to pharmacists dispensing mifepris-
tone. It was through the purposeful partnerships that were formed that the right knowledge
and evidence could be shared and then mobilized to produce change within Health Canada.
Specifically, this was communicated in interviews when P742 and P413 described giving pre-
sentations to the regulatory bodies that shared the most recent evidence on the safety of phar-
macist dispensing of mifepristone.
Additionally, research findings, or knowledge, were mobilized by the CART team and com-
municated to the media. The CART team was able to use knowledge translation to take their
research data that indicated that the restrictions in place were limiting provision of medical
abortion and bring it to a new set of knowledge users. Through a series of news articles [20–
22,24] the team was able to engage the public and the wider health care community with the
evidence supporting a proposed repeal of Health Canada’s regulations.
Develop coalitions: Demonstrating a commitment to customers and service. Partici-
pants’ attitudes and experiences demonstrated a commitment to the delivery of equitable
reproductive care to individuals in BC. The impetus for the project was the data found in
CART’s initial research article that demonstrated a lack of access to abortion care for many
individuals living outside of urban communities. [4] The hospital executive at BC Women’s
Hospital mobilized their value of reproductive choice for all women to support the project
team and provide support and testimony of impact to further highlight the critical nature of
the restriction on mifepristone access. It was clear from the interviews that a dedication to
improving access for individuals seeking abortion care was a top priority for the project: “It’s
about good care” (P390).
Develop coalitions: Navigating socio-political environments. Another key theme
expressed by participants during the interviews was that of autonomy. We found that partici-
pants identified that team members were encouraged to work towards the clear goal of the
project but did not feel they were being closely monitored or supervised. Communication
between stakeholders occurred on a regular basis and was bi-directional.
“Communication processes were set up so that we are always informed of where things
were at.” (P519)
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This high level of autonomy could be attributed to the pre-existing relationships between
the members of the team and the trust and mutual respect that was already present. One par-
ticipant summarized this with the following quotation:
“Collegial, professional, trusting relationships were already in place, enabling the rapid
exchange and initiation of ideas and recommendations for change.” (P629)
Achieve results. In the LEADS Framework, achieving results is a key component of being
a successful leader. [14] Specifically, the framework emphasizes that strong leaders may act
before all individuals in an organization are on board and are able to mobilize the resources
available to them to make public health change. [27] The four key capabilities of the Achieve
Results domain are: a) setting direction, b) strategically aligning decisions with vision, values,
and evidence, b) taking action to implement decisions, and c) assessing and evaluating. [27]
Our analysis of interviews and documents suggests that the project was successful demon-
strating all four of these capabilities, and in achieving three main results: providing evidence to
support pharmacist dispensing of mifepristone, providing physicians and pharmacists in BC
with regulatory support to work outside of Health Canada regulations, and contributing to
changes to the Health Canada regulations for mifepristone.
Achieve results: Setting direction. Participants suggested an experience of shared and
aligned values. Specifically, the values of the many organizations involved lined up to make the
project successful. The direction of the organizations supported pharmacists, physicians, and
individuals in BC seeking abortion care. The leadership at BC Women’s Hospital had already
worked diligently to foster an environment that championed reproductive choice throughout
an individual’s reproductive lifetime. The College of Pharmacists of BC had a clear vision that
it was the role of the provincial regulator, rather than that of Health Canada to regulate phar-
macists’ dispensing practice. The College of Pharmacists of BC also expressed their dedication
to equitable access to all medications for the individuals in BC. The College of Physicians and
Surgeons of BC were concerned about access to abortion care and the undue burdens placed
on both individuals seeking care and the physicians providing that care. The UBC Faculty of
Pharmaceutical Science also demonstrated values of justice and equity, among others. Finally,
CART’s goal also aligned as they aimed to use evidence to support health policy and service
decisions able to provide Canadians the ability to plan their pregnancies. A key to success of
the project was the alignment of the direction and vision of multiple organizations, which
ensured the commitment of the parties involved.
Achieve results: Strategically aligning decisions with vision, values, and evidence. This
domain stresses the importance of understanding the complex nature of the health care system
and “aligning strategy with structure, culture and skills.” [27] The interviews demonstrated
how the success of the project was dependent on the ability of the leaders involved to create a
network working for change made up of many different organizations. In many of the inter-
views, individuals commented on the clear communication that occurred between the groups:
communication was “bi-directional with real-time sharing of information” (P413). The project
was able to use the strengths and expertise of each organization, coming together with “The
right people . . . the right institution . . . the right political party” (P629) to create change.
Achieve results: Taking action to implement decisions. Through the interviews we were
able to gain more information on the actions taken to create change as outlined above in
Results. As noted, participants also commented on the bi-directional communication that
occurred between the members of the project, with sharing of progress and setbacks among
team members occurring on a regular basis. Additionally, decisive action was taken on the
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part of the members involved, demonstrated by an immediate response to the Health Canada
regulations on mifepristone.
Finally, clarity was stressed as a component that was integral to the success of the team. par-
ticipants described clarity around evidence, policy and practice that allowed them to focus on
results.
“Clarity was most important, having people in BC who were really able to articulate why
change needed to happen, how they could help make that happen and why the barriers that
have been conceived . . . were actually doing more harm to patients.” (P629)
Within the LEADS Framework, creativity in response to challenges is discussed as a build-
ing block of this capability. One participant described that: “knowing who to use and how to
use them is creative” (P519), showing that clarity and creativity were both used to achieve
change. This participant was referring to the ability to recognize team members’ strengths and
areas of expertise and make the best use of them as being creative and necessary to success,
instead of confining everyone only to their formal roles within an organization. Additionally,
another participant described the following:
“Adaptability and creative ways of interacting with stakeholders and health policy makers
in multiple ways and in varied settings (e.g. one-on-one meetings; Board meetings, Confer-
ences etc.) was essential [to success].” (P413)
Achieve results: Assessing and evaluating. This domain was not as relevant to the leader-
ship of the project. The project was self-limited in that it concluded when the desired change
to regulation was instated. Ongoing formal performance assessments and metrics were not
commented on in the interviews, instead progress was measured by the changes made to the
problematic dispensing regulations.
Systems transformation. Finally, the LEADS Framework also states that systems trans-
formation is needed to improve the Canadian health sector. [28] Strong leaders require a deep
understanding of the nuanced economic, budgetary, technological, and inter-disciplinary con-
siderations that must align in order to successfully create change in a complex and constantly
evolving system. [28] The four key capabilities of the Systems Transformation Domain are: a)
demonstrating systems/critical thinking, b) encouraging and supporting innovation, c) orient-
ing strategically to the future and, d) orchestrating change. [28]
Systems transformation: Demonstrating systems/critical thinking. This capability
focuses on the understanding of the health care system in which the work is being done (in
this case, both BC and Canada) and then using critical thinking skills to determine which
health care modalities will work in future health systems. [28] Each participant had in-depth
knowledge and experience with their particular domain and then a greater understanding of
the way in which this domain fit into the larger provincial and national health system.
“(We) had a pretty good understanding of how the system is supposed to work . . . the regu-
lation of the professions and who does what is entirely within the domain of the provinces.”
(P390)
“It (the regulation) struck us as simply not how medicine and pharmacy work as practiced
in BC.” (P328)
Participants communicated that this knowledge was one of the reasons that the issues with
prohibiting pharmacists from dispensing mifepristone were identified (cost, safety, skill) and
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also how the solution to this issue was identified (health professional practices are governed by
their provincial “College,” not by the federal drug regulator Health Canada).
Systems transformation: Encouraging and supporting innovation. The second capabil-
ity in the systems transformation domain describes the importance of Quality Improvement
and using models such as the Plan-Do-Study-Act cycle (PDSA) of innovation. [28,29] The
PDSA cycle is a framework created by the National Health System (NHS) in the UK to guide
implementation of novel changes in a regulated and controlled fashion. The system is impor-
tant in leadership because it allows for innovation to be both supported and introduced in a
way that encourages ongoing evaluation. [28,29] Participants in this project generally did not
coalesce to craft a formalized PDSA cycle for the project. However, some elements were pres-
ent in the work that was carried out. The team planned an intervention and then carried it out.
Similarly, starting from the 2015 announcement of the restrictive mifepristone regulation in
Canada, CART planned a national study very similar to a PDSA cycle, the “CART-Mifepris-
tone Implementation Study” [17] (funded in July 2016 as noted above by CIHR and MSFHR).
Throughout the study iterative cycles of engagement such as described here with research data
being generated and then shared with stakeholders and knowledge users throughout Canada,
have been undertaken to present evidence, change policy, and to assess the outcomes. This has
been undertaken through news articles [20–22]research papers [17]and through annual meet-
ings of the CART team. [18] One participant also raised the importance of recognition of
accomplishments “We really do need to give credit” (P519) when discussing teamwork.
Systems transformation: Orienting strategically to the future. An orientation to the
future was clearly expressed by many of the participants. Specifically, the CART team recog-
nized that the future of abortion care in Canada had the potential to change significantly with
the introduction of mifepristone, but that the full potential of medical abortion would only be
realized if change to dispensing regulations were made. The values of the regulatory colleges as
well as BC Women’s Hospital reflected the future of health care: a system that is patient cen-
tred, multi-disciplinary, and collaborative. [30]
Systems transformation: Championing and orchestrating change. The final capability
of the Systems Transformation domain discusses how leaders are aware and understanding of
the relationships between stakeholders and other knowledge users and individuals within the
health system. A leader can support and stimulate engagement from a variety of different
groups in order to generate change. [28] As described by the participants, multiple organiza-
tion were involved in the project. Stakeholder and professional engagement were successfully
achieved. In the interviews, what became clear was that the members of the project understood
that change to medication policy was not a matter that should be addressed only by research-
ers, physicians, hospital administration, government, or pharmacists independently, but rather
a process that can only be successful when all of the above entities are given a seat at the table.
When discussing the beginning of the project, participant 1 stated they had:
“A plan to gather more collaboration and information and connection to understand what
the timeline and processes might be moving forward.” (P742)
One participant expressed that the engagement of such a wide variety of stakeholders “pro-
vided the government with reassurance that it is not just one group with a vested interest”
(P519) who is pursuing change and thus the presence of the wide-based coalition helped to
provide legitimacy to the project.
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Discussion
The purpose of this study was to investigate the leadership skills that were used to advocate for
changing, and successfully removing, the restrictions on pharmacists dispensing mifepristone
in BC within the course of twelve months in 2016–2017. We completed document analysis to
determine a clear timeline of events and conducted interviews with individuals identified
through snowball sampling. We analyzed the interviews using the LEADs framework in an
effort to determine what factors contributed to successful policy change. The policy change
work was carried out by a group of individuals from a variety of backgrounds including medi-
cine, research, pharmacy, hospital administration, and government.
Our case study identified the characteristics of the stakeholder team that typified the
LEADS capabilities of Develop Coalitions, Achieve Results, and Systems Transformation. The
LEADS framework provides a formal way to conceptualize the qualities necessary for success-
ful health care leadership. [14] The domains and capabilities overlap and interact with each
other, reflecting that leadership is constantly evolving and changing. [14] The LEADS frame-
work has been proposed as a common language to assist individuals in navigating health care
leadership and creating change. [15] Specifically, knowledge transfer, evidence sharing, auton-
omy, shared values, and clarity were qualities of the group’s work that were highlighted as
being integral to success. The existing collegial and trusting relationships between key stake-
holders allowed for interdisciplinary collaboration, rapid mobilization, and identification of
issues and finally facilitated the success of the project itself.
An important finding of this case study is that there was no formal leadership position
given to any individual in the project. The work was done by leaders who worked in parallel,
engaging with each other as needed while each working within their own organization and
area of expertise to achieve a common goal of the project. This provided some difficulty to uni-
formly apply the LEADS Framework which is designed for more formal team environments.
Participants did not report that there were clear guidelines set for conflict resolution as sug-
gested by LEADS. [26] The framework does not specify the content of conflict guidelines but
highlights the importance of having an agreed upon process of dealing with conflict before it
occurs. In the case where a group involves individuals that are less well known to each other,
these guidelines would help to navigate the socio-political environment of the team. Conflict
resolution skills and training have been shown to improve both teamwork and productivity as
well as job satisfaction. [31] One participant did provide information on the mutual respect
between team members that has in the past lead to the successful navigation of disagreements,
but that none occurred, to their knowledge, during the project. There were no disagreements
mentioned in the data and so the need for these guidelines was low. In a situation of collabora-
tive groups with mutual trust and respect, working more in parallel, it may not be practical or
necessary to establish formal guidelines.
Most participants also did not describe ongoing assessment and evaluation following com-
pletion of the project, although this is a central feature of the CART-mifepristone implementa-
tion research. Although metrics and formal performance assessments may not have been
relevant to the project, post-project reflection and documentation in the form of an after-
action review may have been helpful. Completion activities are recognized as an important,
but often neglected, aspect of project management. [32] They serve to identify potential areas
for improvement and to provide a guide to other individuals working in other domains who
might benefit from the expertise and experience of the groups involved. [32] This study fills
part of that gap. The CART team has ongoing plans to evaluate how provision of medical abor-
tion in Canada has changed as a result of changing regulations. Importantly, most participants
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were not aware of these ongoing assessments and so communication from the CART team
could be improved.
One participant raised recognition as an important opportunity for improvement. The
domain of Systems Transformation includes the importance of supporting innovation, which
includes recognition of the work of team members, as a way to encourage ongoing engage-
ment with system change. Participants did identify that the team was very strong in fostering a
community where all stakeholders were invested in the outcome and felt that their work mat-
tered. Recognition of leaders, especially in a health care setting, has been acknowledged as a
key component to retaining and supporting individuals in leadership roles. [33]
Our analysis provides evidence that the leadership skills of the team members were a key
contributor to the removal of mifepristone restrictions. However, we do acknowledge that
leadership alone is not the only requirement for health policy change. The process often con-
sists of complex interactions of policy, problems, and politics as described by Kingdon. [34] It
is important to note that the success of the project was also likely supported by opportune tim-
ing in which there was a problem that needed solving, a favourable political climate, and the
appropriate policy makers with motivation to change regulations in BC. [34]
Abortion services can be a potentially contentious or sensitive topic for health care systems.
A shared vision and belief in the importance of access to abortion care for Canadians was
another driving force behind the success of the project. However, participants’ lobbying for
change to provisions in prescribing practices also relied on the beliefs that these restrictions
were in direct disagreement with current prescribing practices and policies in BC. This over-
arching belief was likely important to success as it meant the project focused on a flaw in poli-
cies regulating prescribing and dispensing medications broadly, not abortion specifically.
Strengths and limitations
Our interviews were completed in 2019 and the project concluded in 2017. This delay between
action and interview likely contributed to participants’ limited recall of certain details. How-
ever, all participants did provide a very similar sequence of events. Through our analysis of
news media and journal articles we were able to corroborate timelines. Additionally, there was
no conflict reported between group members or instances where the group had to alter its
strategy or approach. It is possible that the time delay described above made it difficult for par-
ticipants to remember any negative aspects of working together that may have occurred. As
well, given that the overall goal of the project was achieved, the participants may have been less
likely to remember aspects that did not work well from a team/leadership perspective despite
our specific probing questions in the interviews. Our inclusion of analyses of correspondence
between participants and minutes from meetings, neither of which reflected negative or unsuc-
cessful stages in the project, mitigates against this recall bias. There have been many examples
where, despite strong leadership, policy change has not been successful. Recently, in Quebec,
Canada, efforts to improve access to medical abortion have been unsuccessful. [35]
Conclusion
The results of analysis of the interviews and documents provide valuable insight into the work-
ings of a successful group committed to a common goal. Document analysis also provided a
clear timeline of the work completed and suggested that strong communication between team
members was key to success. The existing collegial and trusting relationships between key
stakeholders allowed for interdisciplinary collaboration, rapid mobilization, and identification
of issues as well as facilitating a successful change to mifepristone dispensing regulations in
Canada. A lack of awareness of the CART plans for post-project assessment, such as this study,
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was identified as a possible limitation to the work of the team. In future iterations of this team,
we could incorporate planned assessments/evaluations and thus strengthen dynamics, espe-
cially when a desired outcome is not achieved.
In addition to improving future work within BC, the analysis provided may be helpful to
other national or international organizations by identifying the key leadership attributes that
contributed to success. Medical abortion continues to be difficult for individuals to access
globally, with many of the same (or more severe) restrictions to provision in place in settings
around the world. [36] These qualities could be cultivated and encouraged in local teams and
combined with other national health care leadership frameworks in use in non-Canadian juris-
dictions, such as Health LEADS Australia or the UK’s Healthcare Leadership Model to aug-
ment the results to improve applicability. [15] The study also provides guidance on the
mobilization of research data to create change through increased public awareness, which was
very important to the project and can be used in international settings. Through showing an
example of leadership success we hope to provide a blueprint for other teams working to drive
change in important areas. We demonstrated that existing collegial and trusting relationships
between key stakeholders allowed for interdisciplinary collaboration, rapid mobilization, and
identification of issues that facilitated successful Canadian global-first deregulation of mifep-
ristone dispensing.[36]
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